Document:

EX-10.8 MARKETING SERVICES AGREEMENT

 

Exhibit 10.8

AGREEMENT FOR MARKETING SERVICES

     THIS AGREEMENT FOR MARKETING SERVICES (the “Agreement”) is made and entered into this
14th day of January, 2008 (the “Effective Date”), by and between ALPS Fund
Services, Inc. a Colorado corporation located at 1290 Broadway, Suite 1100, Denver, Colorado 80203
(“ALPS”) and GreenHaven Commodity Services, LLC, a Delaware limited liability company
located at 3340 Peachtree Road, Suite 1910, Atlanta, Georgia 30326 (the “Client”). ALPS
and the Client are sometimes hereinafter individually collectively referred to as a “Party”
and collectively as the “Parties”.

     WHEREAS, the Client is the managing owner of GreenHaven Continuous Commodity Index Tracking
Fund, a Delaware statutory trust that is listed on the American Stock Exchange (the “Feeder
Fund”), and of GreenHaven Continuous Commodity Index Master Fund, a Delaware statutory trust
and a commodity index-linked fund in which the Feeder Fund has invested all of its assets (the
“Master Fund”; collectively with the Feeder Fund, the “Funds”); and

     WHEREAS, ALPS provides certain professional services to entities such as the Funds and

     WHEREAS, the Client desires to engage ALPS to perform the services described below for the
Funds and ALPS desires to accept such appointment.

     NOW, THEREFORE, in consideration of the mutual covenants herein contained, the Parties hereto
agree as follows:

     1. Scope of Services. ALPS agrees to perform for the Funds the services listed on
Exhibit “A” hereto (collectively, the “Services”).

     2. Fees. For the performance by ALPS of the Services pursuant to this Agreement,
Client agrees to pay ALPS an annual fee, amortized monthly and payable quarterly, based upon the
gross management fees paid by the Master Fund to the Client, in accordance with the fee schedule
set forth on Exhibit “B” hereto. Such fees, as well as ALPS’ out-of-pocket expenses and
advances identified in Section 3 below, may be changed from time to time by mutual written
agreement of the Parties.

     3. Out of Pocket Expenses. In addition to the fees that the Client shall pay to ALPS
pursuant to Section 2 above, the Client agrees to reimburse ALPS for its reasonable out-of-pocket
expenses incurred and advances made by ALPS in performing the Services, including, but specifically
not limited to, regulatory filing fees. In addition, any other expense incurred by ALPS at the
specific written request or consent of the Client will be reimbursed by the Client.

     4. Invoicing. The Client agrees to pay ALPS’ invoices for fees and expenses within
thirty (30) days following the Client’s receipt of ALPS’ respective billing invoice, other than any
fees or expenses that are subject to a good faith dispute between the Parties. In the event of
such a dispute, the Client may only withhold that portion of the fee or expense that is subject to
the dispute. The Client shall notify ALPS in writing within ten (10) calendar days following the
receipt of each invoice with respect to which the Client has a dispute. If the Client does not
provide such notice of dispute within the required time, then the billing invoice will be deemed

 

 

accepted. The Client shall settle such disputed amounts within ten (10) business days from the day
upon which the parties agree on the amount to be paid, or at such later date as may be agreed upon
by ALPS, by payment of the agreed-upon amount. If no agreement is reached, then the Parties may
exercise their specific legal remedies.

     5. Term. The term of this Agreement shall commence upon the Effective Date and shall
continue thereafter for two (2) years (the “Initial Term”), unless terminated sooner in
accordance herewith. After the Initial Term, this Agreement will renew automatically for additional
one year periods of time (each, a “Renewal Term”, and collectively with the Initial Term,
the “Term”), unless one Party hereto provides the other Party with written notice of
termination at least sixty (60) days prior to the expiration of the Initial Term or the
then-current Renewal Term

     6. Indemnification. Each Party (the “Indemnifying Party”) hereby agrees to
indemnify and hold harmless the other Party (the “Indemnified Party”) against any and all
losses, costs and expenses (including reasonable attorney’s fees) that the Indemnified Party incurs
by reason or as a result of or arising from the breach by the Indemnifying Party of any
terms, provisions, covenants, warranties or representations contained herein and/or in connection
with the enforcement of this Agreement or any provision hereof.

     7. Confidentiality. During the Term of this Agreement, each Party may be provided
access to selected information of the other Party, oral, written, or electronic, including but not
limited to information which relates or refers to the other Party’s: business planning; internal
controls; computer, data processing, or communications architectures or systems; electronic data
processing architectures, applications, programs, routines, or subroutines; business affairs and
methods of operation or proposed methods of operations, techniques or systems; or financial or
other non-public information of the other Party (hereinafter, “Confidential Information”).
Each Party agrees to treat confidentially and not disclose to any third parties (other than its
directors, managers, partners, officers, employees and agents who agree to be bound hereby) such
Confidential Information, and to only use such Confidential Information in performing under this
Agreement. The obligations set forth in this Section 7 shall survive for a period of three (3)
years from the termination of this Agreement; provided, however, that with respect to any
Confidential Information that would constitute a “trade secret”, the obligation of confidentiality
and non-use shall survive as long as such trade secret information is entitled to such treatment as
a matter of law.

     In the event that a Party receives a subpoena or other validly issued administrative or
judicial process requesting Confidential Information, such Party shall provide actual notice and a
copy of the subpoena or other document(s) to the other Party within twenty-four (24) hours of such
receipt and shall not comply with such subpoena or other process until the earlier to occur of (1)
receiving written notification from the other Party that it may proceed or (2) the deadline for
complying.

     The Parties acknowledge that, because of the nature of the Confidential Information, the owner
of such Confidential Information would suffer irreparable harm in the event of a material breach of
the provisions of this Agreement and that monetary damages would be inadequate to compensate such
Party for such a breach. As a result, in the event of any material breach or threatened material
breach by the other Party of any such provisions, the non-breaching Party shall be entitled, in
addition to such other legal or equitable remedies which might be available,

 - 2 -

 

to injunctive relief in any court of competent jurisdiction against the threatened material breach
or continuation of any such material breach without showing or proving any actual damages sustained
by the non-breaching Party.

     8. Termination. Either Party may terminate this Agreement upon thirty (30) days
written notice to the other Party in the event of a material breach of this Agreement by the other
Party which is not cured by the end of such thirty (30) day.

     9. Notices. All notices, invoices and other communications required or permitted to
be given under this Agreement shall be in writing and shall be deemed to have been duly given upon
actual receipt by the notified party either by hand, by facsimile (with evidence of receipt) or by
electronic (email) delivery, one (1) day following delivery to an overnight courier service (such
as United Parcel Service or Federal Express), or three (3) days following delivery to the U.S.
Postal Service if sent by certified mail, return receipt requested, at the address herein
identified above, or such other address as any Party hereto shall hereafter specify by written
notice to the other Party or Parties hereto.

     10. Arbitration. All claims, disputes, controversies and other matters in question
between the parties to this Agreement arising out of or relating to this Agreement or the breach
thereof that cannot be resolved by the Parties shall be settled by binding arbitration in
accordance with this Agreement and the following procedures or such other procedures as may be
agreed upon by the Parties:

          (a) Either Party may serve upon the other Party, in accordance with the notice procedures set
forth in Section 9 above, a written demand specifying in reasonable detail the nature of the matter
and that the claim, dispute, or controversy or other matter in question shall be submitted to
arbitration. The demand shall be made within a reasonable time after the claim, dispute,
controversy or other matter in question has arisen. In no event shall the demand for arbitration
be made after the date when institution of legal or equitable proceedings, based upon such claim,
dispute, controversy or other matter in question, would be barred by the applicable statute of
limitations or by laches.

          (b) After service of a demand for arbitration, the Parties shall attempt to agree upon a
single arbitrator within ten (10) calendar days or such longer period as the parties may agree.

          (c) In the event the Parties cannot agree upon a single arbitrator within the period
established under paragraph (b) above, then each Party shall appoint one arbitrator within an
additional ten (10) calendar days and notify the other Party of such appointment. If either Party
fails to timely appoint an arbitrator, then the arbitrator appointed by the other Party shall be
the sole arbitrator. If, however, both Parties appoint an arbitrator, then a third arbitrator
shall be selected within ten (10) calendar days thereafter by the first two arbitrators unless
otherwise agreed by the Parties. If the arbitrators and the Parties fail to appoint a third
arbitrator, either Party may request the American Arbitration Association or any federal or local
court in Denver, Colorado to appoint the third arbitrator.

          (d) Except as otherwise provided herein, any arbitration proceeding shall be conducted in
accordance with the rules and procedures of the American Arbitration Association or such other
rules and procedures as are agreed to by the arbitrators or the Parties. Nothing

 - 3 -

 

contained herein shall be construed as requiring submission of any claim, dispute, controversy or
other matter in question to the American Arbitration Association.

          (e) The arbitration proceeding shall be held in Denver, Colorado, unless otherwise agreed by
the arbitrators or the Parties.

          (f) The decision rendered through arbitration shall be final and binding upon the Parties
hereto, and judgment may be entered in accordance with applicable law in any court having
jurisdiction thereof. In rendering a decision, the arbitrators shall be governed by the terms of
this Agreement.

          (g) Although the Parties agree that compulsory and binding arbitration shall be the exclusive
means of dispute resolution, judicial review of any arbitration decision or proceeding (other than
entry or enforcement of an arbitration award/judgment) or of any matter arising under the terms of
this Agreement, whether or not submitted to the binding arbitration process required by this
Agreement, shall be brought solely in the federal or state courts in Denver, Colorado.

          (h) The foregoing procedures shall not preclude either Party from pursuing all available legal
remedies for infringement of a registered patent, trademark, service mark, or copyright.

     11. Governing Law. This Agreement shall be deemed to have been made in the State of
Colorado, and shall be governed by, construed and enforced in accordance with the law of the State
of Colorado, without reference to principles of conflicts of laws thereof.

     12. Captions. The section headings used in this Agreement are intended solely for
convenience of reference and shall not in any way or manner amplify, limit, modify or otherwise be
used in the interpretation of any of the provisions of this Agreement. The masculine, feminine, or
neuter gender and the singular or plural number shall be deemed to include the others whenever the
context so indicates or requires.

     13. Counterparts. This Agreement may be executed in one or more counterparts, each of
which shall be deemed an original and all of which counterparts together shall constitute but one
and the same instrument.

     IN WITNESS WHEREOF, the Parties hereto have caused this Agreement to be executed by their
respective duly authorized officers as of the date initially set forth above.

	 	 	 	 	 	 	 	 	 	 	 
	ALPS Fund Services, Inc.	 	 	 	GreenHaven Commodity Services, LLC	 	 
	 
	 	 	 	 	 	 	 	 	 	 
	By:

	 	 	 	 	 	By:	 	 	 	 
	 

	 	 
	 	 	 	 	 	 	 	 
	 

	 	Thomas A. Carter
	 	 	 	 	 	Ashmead F, Pringle III	 	 
	 

	 	Managing Director
	 	 	 	 	 	Manager	 	 

 - 4 -

 

EXHIBIT A

The Services

     ALPS will provide the following Services to the Funds:

Marketing Staff:

	 	 	 	– Write, design and produce NASD-approved sales and marketing materials.
	 
	 	 	 	– Create NASD-approved seminars and product presentations.
	 
	 	 	 	– Coordinate advisor specific advertising with advertising agency.
	 
	 	 	 	– Manage marketing budget.
	 
	 	 	 	– Create and maintain website.

Registered Representative Call Center:

	 	 	 	– Outbound follow-up calls on 100% of phone and internet requests for information.
	 
	 	 	 	– Receive creation/redemption call & communicate with AP/Advisor/Custodian.
	 
	 	 	 	– Transfer “hot” advisor leads to internal wholesaler.
	 
	 	 	 	– Support dedicated GEMS toll free line for advisors.

Five (5) Internal Wholesalers:

	 	 	 	– Support National Accounts Manager’s and wholesalers field activities.
	 
	 	 	 	– Telemarket to independent financial planners.
	 
	 	 	 	– Coordinate conference participation.
	 
	 	 	 	– Attend various conferences.

Ten (10) External Wholesalers

     Assist the national accounts manager in implementing the tactical sales strategy.

	 	 	 	– Establish regional relationships with wire houses and fee based advisors.
	 
	 	 	 	– Deliver product education presentations.
	 
	 	 	 	– Conduct product education presentations with wire house
brokers and fee based financial advisors.
	 
	 	 	 	– Attend major fee based advisor conferences.

     ALPS Senior Management:

	 	 	 	– Develop overall strategic sales and marketing plan with National
Accounts Manager, Advisor and Specialist firm.

 - 5 -

 

	 	 	 	– Supervise sales related activities.
	 
	 	 	 	– Participate in field sales activities.

National Accounts Manager:

	 	 	 	– Implement tactical sales strategy.
	 
	 	 	 	– Establish home office contacts with targeted broker/dealers.

     Develop product education presentations.

	 	 	 	– Conduct product education presentations with fee based financial advisors.
	 
	 	 	 	– Attend major fee based advisor conferences.

 - 6 -

 

EXHIBIT B

Fees

	 	 	 	 	 
	Master Fund Assets	 	ALPS Fees as a % of Management Fees
	$0-100,000,000

	 	 	6	%
	$100,000,000-$200,000,000

	 	 	8	%
	$200,000,000-$500,000,000

	 	 	10	%
	$500,000,000-$1,000,000,000

	 	 	12	%
	$1,000,000,000+

	 	 	18	%

 - 7 -EX-10.1 FORM OF SUBSCRIPTION AGREEMENT

 

Exhibit 10.1

SUBSCRIPTION AGREEMENT

     The undersigned (“Subscriber”), a resident of                     , hereby subscribes for and agrees to
purchase and pay for an aggregate of (a)                      shares1 (the “Shares”) of the common
stock, par value $0.001 per share (the “Common Stock”), of GeoVax Labs, Inc., an Illinois
Corporation (“GeoVax”), and (b) common stock purchase warrants (the “Warrants”) to purchase an
aggregate of                      shares (the “Warrant Shares”) of the Common Stock, for aggregate consideration
of $                     (the “Aggregate Purchase Price”), on the terms and conditions set forth herein. The
Shares, the Warrants and the Warrant Shares are sometimes collectively referred to herein as the
“Securities.”

A. Payment of the Aggregate Purchase Price hereunder shall be made by either (a) wire transfer of
immediately available funds pursuant to GeoVax’s wire transfer instructions, or (b) check made
payable to “GeoVax Labs, Inc.” and delivered to GeoVax Labs, Inc., 1256 Briarcliff Road, N.E.,
Emtech Bio Suite 500, Atlanta, Georgia, 30306.

B. In order to induce GeoVax to accept this subscription, and in order to determine whether
Subscriber is qualified to acquire the Securities pursuant to an exemption from the registration
requirements of the Securities Act of 1933, as amended (“Act”), provided by Section 4(2) of the Act
or Regulation D promulgated thereunder, and pursuant to any other applicable laws regulating the
offer and sale of securities in the state or states in the United States in which Subscriber is
domiciled, Subscriber hereby represents, warrants and certifies that:

	 	1.	 	Subscriber has been fully informed to its complete satisfaction concerning
the organization aspects, business, limited current operations, finances, and all
other matters relating to GeoVax which it consider significant for the purpose of
making an investment decision with respect to the Securities. In particular,
Subscriber has examined GeoVax’s most recent annual report on Form 10-K and its most
recent quarterly filings on Form 10-Q. Subscriber has been offered the opportunity to
discuss GeoVax and its affairs with members of GeoVax’s management, to review such
documents and records as it considers appropriate, and has received all information,
which it has requested with respect to GeoVax. Subscriber is aware of the present
concentrated stock holdings of GeoVax.
	 
	 	2.	 	Subscriber is fully aware of all of the risks involved in purchasing the
Securities.
	 
	 	3.	 	Subscriber is aware that there will be limited liquidity in an investment in
GeoVax Securities.
	 
	 	4.	 	Subscriber is aware that the Securities do not carry preemptive rights or
cumulative voting.
	 
	 	5.	 	Subscriber is aware that there can be no assurance that GeoVax will be
profitable in the future.
	 
	 	6.	 	Subscriber is also aware that GeoVax will be in need of additional funds in
order to attempt to fulfill its business plans and there is no assurance that it will
be able to obtain such funds.
	 
	 	7.	 	Subscriber understands that there is only a limited market for GeoVax’s
Securities and that there can be no assurance that an active market will develop in
the future.

 

			
	1	 	Based upon a per share purchase price equal to the
lesser of (a) $0.155 per share and (b) 70% of the closing market price per
share on August 6, 2007.

 

 

	 	8.	 	Subscriber understands that the Securities have not been registered nor have
they been registered or qualified under the applicable securities laws of any state in
the United States, and are being issued in reliance upon the truth and accuracy of the
representations made herein with respect to Subscriber’s investment intent and
suitability as an investor. Subscriber hereby certifies that it is purchasing the
Securities for investment for its own account, with no present intention of making any
sale, transfer or distribution of them. Subscriber understands that the Securities may
not be sold or transferred without registration under the Act, or qualification or
registration under the applicable state securities laws, unless there is an exemption
from such registration or qualification then available. Subscriber consents to having
a legend on the certificates representing the Securities to that effect. Subscriber is
aware that the Shares and the Warrant Shares will carry certain limited registration
rights.
	 
	 	9.	 	Subscriber is a sophisticated investor with substantial experience in
securities of speculative businesses. Subscriber is able to judge the suitability of
this investment for Subscriber and the risks involved, and understands that the
Securities will be unmarketable for an indefinite period of time, and that if GeoVax
is not successful, all or a substantial part of Subscriber’s investment could be lost.
Subscriber further certifies that its net worth or annual income is such that the loss
of Subscriber’s entire investment, or its unavailability, will not result in serious
financial harm or determent to Subscriber.
	 
	 	10.	 	Subscriber is aware that GeoVax may sell the Securities to Subscriber only if
Subscriber qualifies according to the express standards stated herein. If the
Securities are purchased in a fiduciary capacity, the person or persons for whom the
purchase is made meet the standards set forth herein and the representation and
warranties shall be deemed to have been on behalf of the person or persons for whom
Subscriber is so purchasing. Subscriber represents and warrants that it meets the
following investors standards:

	 	11.1	 	Subscriber and its representatives have been afforded access
to such information concerning GeoVax and about the proposed operations of
GeoVax as have been requested by Subscriber or them and that such materials
were sufficient to enable Subscriber to arrive at a reasoned investment
decision with respect to an investment in the Securities.
	 
	 	11.2	 	Subscriber meets one of the standards as an “Accredited
Investor”, as such term is defined in Rule 501(a) of Regulation D.

	 	12.	 	On the terms and subject to the conditions of this paragraph 12, Subscriber
shall have the limited right to register the Shares and the Warrant Shares as
described herein. For purposes of this discussion, the term “Holders” includes those
shareholders that have purchased shares of GeoVax Common Stock under a Subscription
Agreement having terms substantially identical to the terms of this Subscription
Agreement.

	 	12.1	 	“Piggyback” Registration Rights. Holders shall have
the right to register the Registrable Securities under the Act in connection
with future underwritten public offerings of shares of GeoVax Common Stock.
The term “Registrable Securities” means: (i) the Shares issued in connection
with this Subscription Agreement; (ii) the Warrant Shares underlying the
Warrants issued in connection with this Subscription Agreement; and (iii) any
other securities of GeoVax issued as (or issuable upon the conversion or
exercise of any warrant, right or other security which is issued as) a
dividend or other distribution with respect to, or in exchange for or in
replacement of, such securities referenced in (i) and (ii) immediately above,
excluding in all cases, however, any Registrable Securities sold in any public
offering pursuant to a registration or an exemption from registration.

2

 

	 	 	 	On the terms and subject to the conditions stated herein, each time GeoVax
shall determine to file a registration statement under the Act in
connection with the proposed offer and sale for money of any of its shares
of Common Stock in an underwritten public distribution by it (other than
(i) a registration statement relating solely to employee stock option or
purchase plans, or (ii) a registration statement on Form S-4 relating
solely to Rule 145 under the Act), GeoVax shall give written notice of its
determination to Holders; provided, however, that GeoVax shall have no
such obligation if the managing underwriter of the subject proposed
offering objects in a writing addressed to GeoVax to the inclusion of any
Registrable Securities in the subject registration statement or offering.
	 
	 	 	 	Under Holders’ written request, which must have been received by GeoVax
within 20 days after any such notice from GeoVax, GeoVax shall use its
best efforts to cause all such Registrable Securities of which Holders
have requested registration to be included in such registration statement
and in any necessary registration, qualification or other filing under the
applicable state securities or blue sky laws, all to the extent required
to permit the sale or other disposition to be made of the Registrable
Securities to be so registered. In the event that the aggregate number of
Registrable Securities requested by the Holders to be registered in any
underwritten public distribution (the “Piggyback Shares”) exceeds twenty
percent (20%) of the aggregate number of shares of GeoVax Common Stock
being registered in such underwritten public distribution, then the
aggregate number of the Piggyback Shares to be registered and included in
such public distribution shall be reduced pro rata among the Holders of
the Piggyback Shares to twenty percent (20%) of the aggregate number of shares being registered in such underwritten public distribution.
	 
	 	 	 	All Holders proposing to distribute their Registrable Securities through
an underwriting pursuant to this paragraph 12 shall (together with GeoVax
and any other holders distributing their securities through such
underwriting) enter into an underwriting agreement in customary form with
the underwriter or underwriters selected for underwriting by GeoVax. If
any Holder disapproves of the terms of any such underwriting, he may elect
to withdraw therefrom by written notice to GeoVax and the underwriter. Any
Registrable Securities excluded or withdrawn from such underwriting shall
not be withdrawn from such registration except at the election of the
Holder.
	 
	 	 	 	Holders shall cooperate with GeoVax, execute any documents, instrument and
agreements, and take any further actions reasonably necessary to effect
such registrations, qualifications or other filings, and the public
offering in connection therewith shall be paid by GeoVax; provided,
however, that Holders of the Piggyback Shares participating in any such
registration shall bear their pro rata share of the underwriting fees,
discounts and commissions. Holders shall not sell or otherwise transfer
any shares of GeoVax Common Stock held by them which are not included in
the underwritten public offering for a period commencing on the date of
the commencement of the public offering, and ending on the earlier of the
date of termination of the public offering or 90 days from the
commencement of the public offering.
	 
	 	 	 	Notwithstanding any contrary provision of this paragraph 12, GeoVax shall
not be required to effect any registrations under the 1933 Act or under
any state securities laws on behalf of any Holder or Holders if, in the
opinion of counsel for GeoVax, the offering or transfer by such Holder or
Holders in the manner proposed (including, without limitation, the number
of shares proposed to be offered or transferred and the method of offering
or transfer) is exempt from the

3

 

	 	 	 	registration requirements of the 1933 Act and the securities laws of
applicable states.
	 
	 	12.2	 	Termination of Piggyback Registration Rights. The
piggyback registration rights under this paragraph 12 are not transferable or
assignable and shall terminate on the first anniversary of the date of the
issuance of the Registrable Securities to the undersigned Holder.
	 
	 	12.3	 	Expenses of Registration. All expenses incurred in
connection with any registration shall be borne by GeoVax; provided, however,
GeoVax shall not be required to pay any fees of Holders’ legal counsel or any
underwriter fees, discounts or commissions.
	 
	 	12.4	 	No Assurance of State Registration. There can be no
assurance that the state in which a Holder resides will permit the
registration of the Registrable Securities within such state. Accordingly,
even if the Shares and Warrant Shares are subsequently registered under
federal securities laws, of which there can be no assurance, there can be no
assurance that the Shares and Warrant Shares can be registered under
applicable sate law due to merit or other requirements. Accordingly, there can
be no assurance that a Holder will be able to have its Shares and Warrant
Shares registered in its state of domicile or residence, as applicable. In
such event, a Holder would continue to own restricted securities under the
state securities law.

	 	13.	 	Subscriber further represents and warrants that:

	 	13.1	 	Considering all facts in Subscriber’s financial circumstances
(including, but not limited to requirements for current income) Subscriber is
able to bear the economic risk of an investment in the Securities, including a
loss of its entire investment.
	 
	 	13.2	 	Subscriber is purchasing the Securities for its own account
for personal investment purposes only and with no view to or any present
intention, agreement or agreements for the distribution, transfer, assignment,
resale, subdivision or hypothecation thereof, and Subscriber understands that
in any event such Securities will be subject to restrictions against any such
transferability in the absence of registration under the Act.

	 	14.	 	Subscriber has the full power and authority to execute and deliver this
Subscription Agreement and to perform its obligations hereunder and this Subscription
Agreement is a legally binding obligation of Subscriber in accordance with its terms.

C. GeoVax’s obligations hereunder are subject to it having a sufficient number of duly authorized
and unreserved shares of its Common Stock on the Closing Date for issuance of the number of Shares
and Warrant Shares underlying the Warrants to be issued hereunder on such closing date.

Dated:                     

Agreed to and Accepted:

	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	GeoVax Labs, Inc.	 	 	 	Very truly yours,
	 
	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	By:

	 	 	 	 	 	By:
	 	 	 	 	 	 	 	 
	 	 	 	 	 	 	 	 	 	 	 	 	 
	 

	 	 	 	 	 	Name:	 	 	 	 	 	 	 	 
	 	 	 	 	 	 	 	 	 	 	 	 	 
	 	 	 	 	 	 	Social Security #
	 

	 	 	 	 	 	 	 	 	 	 	 	 	 	 

4

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00135-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00135-of-00352.parquet"}]]